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Results – Temporal Dynamics
Figure 4: T=0 fluorescence images (a-e), T=30 fluorescence images (f-j), and T=30 white light images 
(k-o) for each sample. All experimental drugs showed visible fluorescence by hour thirty, compared to the 
negative control. Dexlansoprazole and esomeprazole showed a high degree of aggregation that was not 
observed with the other samples. Fluorescence images enhanced for clarity.
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Abstract
Cancer cells rely on glycolysis even under normoxic conditions. 
The use of this pathway results in measurable intracellular 
acidification, which is characterized as an early event in the 
apoptosis program. The pH is restored by activation of voltage-
gated proton pumps, preventing acidification. Proton pump 
inhibitors (PPIs), such as omeprazole, inhibit the H+/K+-ATPase 
system found at the secretory surface of gastric parietal cells. 
Research has shown that omeprazole is also capable of 
inducing caspase-dependent apoptosis in Jurkat T-lymphocytes. 
However, the effects of PPIs on caspase activity remain largely 
unknown. The goal of this study was to determine the temporal 
dynamics of caspase activity in Jurkat cells treated with 
omeprazole, dexlansoprazole, or esomeprazole for six hours. 
After the incubation period, cells were held in place by anti-
CD71 antibodies on the device’s affinity surface and 
fluorescence microcopy was used to monitor caspase activity in 
real time. Caspase activation was observed over a six-hour 
period with the fluorogenic caspase probe, L-bisaspartic acid 
rhodamine 110 (D2R). Elucidation of the intensity and timing of 







Results – Microfluidic Device Trials
During mitochondrial apoptosis, caspases become active in a 
signaling cascade (Fig. 1) (Susin et al., 2000). Cancer cells 
upregulate proton pumps and hydrogen ion transporters (Huber 
et al., 2010) to maintain alkalinity and avoid apoptosis. When 
these methods of maintaining alkalinity are inhibited, the 
intracellular space becomes too acidic and triggers apoptosis, a 
form of programmed cell death. 
Proton pump inhibitors (PPIs) inhibit gastric acid secretion by 
inactivating proton pumps (Shin, 2008). Currently, PPIs are 
utilized as supportive therapy in patients undergoing 
chemotherapy. Prior research has shown that omeprazole 
directly induces caspase-dependent apoptosis in Jurkat cells 
(Scaringi, 2004), but the capability of PPIs to act as standalone 
cancer treatments remains largely unevaluated. PPIs could 
present a viable, less-toxic alternative to chemotherapeutics.
Introduction
Figure 1: The signaling cascade of mitochondrial apoptosis (Susin et al., 2000).
Figure 2A: Anatomy of a microfluidic device 
attached to an inverted microscope.
Figure 2B: Antibody ladder to adhere cells to 
the microfluidic device for observation.
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Future studies may seek to:
• Verify cell death due to apoptosis via Annexin V staining
• Extend the window of observation beyond 30 hours
• Assess the apoptotic effects of other PPI drugs
• Characterize temporal dynamics of unique caspases
• Evaluate PPIs for their ability to induce caspase activity in 
other cancer cell lines
• Explain disruptions to surface receptors following exposure
• Identify a suitable antibody for microfluidic device trials
All three experimental drugs were shown to induce general 
caspase activity in Jurkat cells within twenty-four hours of 
exposure, with dexlansoprazole exhibiting comparable apoptotic 
activity to doxorubicin at hour 27. Omeprazole and 
esomeprazole showed a slower onset, but still reached 60% 
apoptotic cells by hour 30. These results indicate that the tested 
PPIs induce late-onset apoptosis in Jurkat cells following 
treatment with 100mM of drug for 6 hours. Microfluidic device 
trials revealed that drug-treated cells bind to the affinity surface 
at a much lower percentage than the negative control cells, 
suggesting that PPIs alter the cellular surface in some capacity.
Temporal Dynamics Study
• Cells incubated with 100mM PPI, 
complete medium, & D2R at 37℃ and 
5% CO2 for 6 hours
• Cells re-suspended in complete 
medium and D2R fluorophore
• White light & fluorescence microscopy 
images taken of aliquots from sample 
every 3 hours for a total of 30 hours
• Images processed with ImageJ 
• Fluorescence threshold established
Microfluidic Device Trials
• Incubation repeated from prior study
• Microfluidic devices (Fig. 2A) coated 
with antibody ladder (Fig. 2B)
• Cells adhered, white and green light 
images taken for pre-wash photos
• 1x PBS wash for 5 minutes
• Post-wash images taken
• Imaging repeated every 6 hours
• Images processed with ImageJ
• Binding & apoptotic cell % determined
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Figure 3: Percentage of apoptotic cells by hour for each drug. Error bars represent standard deviation for 
three trials. Percent apoptosis corresponds to general caspase activity. Experimental drugs show 
increased caspase activity over time, with dexlansoprazole showing comparable activity to the positive 
control drug, doxorubicin (100µM), at hours 27 and 30. 
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Initial microfluidic device trials seeking to observe caspase 
activity were severely limited by low cell count. A study was 
performed to determine if PPI treatment reduced binding affinity.
Figure 5: Percentage of bound cells for each drug by hour. PPI-treated cells all 
show a dramatically reduced binding affinity after the 6-hour incubation period.
